Nifty
:
22421.95
Sensex
:
71909.70
-198.50 (-0.88%)
-570.59 (-0.79%)
Nifty
Sensex
:
:
22421.95
71909.70
-198.50 (-0.88%)
-570.59 (-0.79%)

Themis Medicare Ltd.

Pharmaceuticals & Drugs - Global

Rating :
45/99

BSE: 530199 | NSE: THEMISMED

NSE BSE
113.19
01-Oct-2026
  • Open
  • High
  • Low
  • Previous Close
  •  116.85
  •  117.97
  •  110.5
  •  116.46
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  69276
  •  7885510.22
  •  147
  •  64.95

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 1,050.86
  • 26.29
  • 1
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 1,141.80
  • 0.44%
  • 2.50

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 67.11%
  • 3.69%
  • 23.57%
  • FII
  • DII
  • Others
  • 0.01%
  • 0.00%
  • 5.62%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 4.68
  • -2.81
  • -3.58

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -35.55
  • -66.56
  • -62.15

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -22.60
  • -56.46
  • -70.30

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 20.61
  • 24.12
  • 38.30

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 3.14
  • 3.81
  • 4.02

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -0.16
  • -14.70
  • -33.05

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Jun 26
Jun 25
Var%
Mar 26
Mar 25
Var%
Dec 25
Dec 24
Var%
Sep 25
Sep 24
Var%
Net Sales
86.96
97.58
-10.88%
76.53
71.70
6.74%
90.13
93.81
-3.92%
77.99
117.01
-33.35%
Expenses
139.38
107.66
29.46%
72.77
77.49
-6.09%
80.34
85.28
-5.79%
81.08
99.88
-18.82%
EBITDA
-52.42
-10.08
-
3.76
-5.78
-
9.80
8.53
14.89%
-3.09
17.13
-
EBIDTM
-60.28%
-10.33%
4.92%
-8.07%
10.87%
9.09%
-3.96%
14.64%
Other Income
0.99
1.18
-16.10%
3.67
1.55
136.77%
1.28
1.02
25.49%
3.24
1.14
184.21%
Interest
2.98
2.47
20.65%
2.70
2.45
10.20%
2.75
2.79
-1.43%
2.76
2.44
13.11%
Depreciation
2.54
2.55
-0.39%
2.60
2.53
2.77%
2.59
2.54
1.97%
2.57
2.45
4.90%
PBT
36.01
-13.93
-
2.13
-9.21
-
4.87
4.22
15.40%
-5.19
13.37
-
Tax
13.99
0.16
8,643.75%
0.17
-1.46
-
0.29
1.14
-74.56%
0.16
3.50
-95.43%
PAT
22.02
-14.08
-
1.96
-7.75
-
4.58
3.08
48.70%
-5.35
9.87
-
PATM
25.33%
-14.43%
2.56%
-10.81%
5.08%
3.28%
-6.87%
8.44%
EPS
2.67
-1.54
-
0.96
-1.05
-
1.10
0.06
1,733.33%
-0.39
1.55
-

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 26
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Net Sales
331.61
342.24
405.51
381.76
354.32
394.61
230.67
201.59
183.75
209.50
216.66
Net Sales Growth
-12.76%
-15.60%
6.22%
7.74%
-10.21%
71.07%
14.43%
9.71%
-12.29%
-3.30%
 
Cost Of Goods Sold
135.05
112.69
108.22
115.43
100.52
131.00
67.35
51.97
58.82
57.75
55.66
Gross Profit
196.56
229.55
297.30
266.33
253.81
263.62
163.33
149.62
124.94
151.75
160.99
GP Margin
59.27%
67.07%
73.32%
69.76%
71.63%
66.81%
70.81%
74.22%
67.99%
72.43%
74.31%
Total Expenditure
373.57
341.84
356.46
330.26
286.87
298.98
181.18
165.93
181.48
184.98
184.29
Power & Fuel Cost
-
12.20
11.81
13.46
11.83
12.18
11.32
11.49
9.70
8.41
9.77
% Of Sales
-
3.56%
2.91%
3.53%
3.34%
3.09%
4.91%
5.70%
5.28%
4.01%
4.51%
Employee Cost
-
93.52
96.38
82.41
66.15
51.97
39.99
44.28
45.69
44.65
40.00
% Of Sales
-
27.33%
23.77%
21.59%
18.67%
13.17%
17.34%
21.97%
24.87%
21.31%
18.46%
Manufacturing Exp.
-
36.52
44.53
41.64
36.95
40.23
21.41
24.01
22.45
27.46
31.30
% Of Sales
-
10.67%
10.98%
10.91%
10.43%
10.19%
9.28%
11.91%
12.22%
13.11%
14.45%
General & Admin Exp.
-
39.91
37.72
29.71
24.29
18.66
12.03
14.05
17.57
18.93
18.86
% Of Sales
-
11.66%
9.30%
7.78%
6.86%
4.73%
5.22%
6.97%
9.56%
9.04%
8.70%
Selling & Distn. Exp.
-
29.27
31.33
29.30
26.74
26.08
14.92
12.28
17.71
18.27
16.70
% Of Sales
-
8.55%
7.73%
7.67%
7.55%
6.61%
6.47%
6.09%
9.64%
8.72%
7.71%
Miscellaneous Exp.
-
17.74
26.48
18.30
20.40
18.86
14.16
7.86
9.54
9.51
16.70
% Of Sales
-
5.18%
6.53%
4.79%
5.76%
4.78%
6.14%
3.90%
5.19%
4.54%
5.53%
EBITDA
-41.95
0.40
49.05
51.50
67.45
95.63
49.49
35.66
2.27
24.52
32.37
EBITDA Margin
-12.65%
0.12%
12.10%
13.49%
19.04%
24.23%
21.45%
17.69%
1.24%
11.70%
14.94%
Other Income
9.18
9.36
4.67
4.76
11.50
6.54
3.62
3.46
2.67
3.49
3.32
Interest
11.19
10.69
10.04
9.38
9.56
8.77
12.71
12.88
11.82
11.87
11.84
Depreciation
10.30
10.32
9.93
12.25
10.49
9.48
8.55
8.27
7.99
7.42
7.47
PBT
37.82
-11.25
33.75
34.64
58.90
83.92
31.86
17.97
-14.87
8.74
16.37
Tax
14.61
0.78
9.84
9.92
15.61
22.38
5.63
2.09
-1.84
0.10
1.60
Tax Rate
38.63%
-6.44%
29.16%
28.64%
26.50%
26.67%
17.67%
11.63%
12.37%
1.14%
9.77%
PAT
23.21
1.14
29.83
43.52
56.90
72.88
35.70
24.78
-13.01
8.70
14.77
PAT before Minority Interest
23.21
1.14
29.83
43.52
56.90
72.88
35.70
24.78
-13.03
8.64
14.77
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.02
0.06
0.00
PAT Margin
7.00%
0.33%
7.36%
11.40%
16.06%
18.47%
15.48%
12.29%
-7.08%
4.15%
6.82%
PAT Growth
361.37%
-96.18%
-31.46%
-23.51%
-21.93%
104.15%
44.07%
-
-
-41.10%
 
EPS
2.52
0.12
3.24
4.73
6.18
7.91
3.88
2.69
-1.41
0.94
1.60

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 26
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Shareholder's Funds
398.58
402.60
377.67
339.44
287.49
218.51
183.02
158.09
168.91
152.44
Share Capital
9.21
9.20
9.20
9.20
9.20
9.19
9.19
9.18
9.18
9.04
Total Reserves
389.37
393.40
368.46
330.17
278.05
208.95
173.35
148.31
159.18
141.36
Non-Current Liabilities
33.17
29.31
35.77
35.39
30.77
24.33
7.51
2.71
6.72
7.60
Secured Loans
19.64
16.39
21.19
18.62
10.91
5.73
0.09
0.14
0.01
0.47
Unsecured Loans
2.22
2.22
5.59
9.83
12.97
16.47
11.76
9.21
11.48
11.93
Long Term Provisions
1.94
1.87
1.60
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Current Liabilities
172.01
165.99
162.28
149.38
123.52
128.31
154.81
146.69
124.94
124.17
Trade Payables
50.84
51.44
47.29
40.04
31.87
30.79
29.68
35.04
30.55
31.63
Other Current Liabilities
58.82
53.68
49.95
40.28
29.93
39.09
46.86
43.72
29.76
38.13
Short Term Borrowings
53.13
43.35
47.36
48.91
43.10
56.93
76.61
66.86
63.73
53.45
Short Term Provisions
9.22
17.52
17.68
20.14
18.61
1.49
1.66
1.07
0.90
0.95
Total Liabilities
603.76
597.90
575.72
524.21
441.78
371.15
345.34
307.47
300.51
284.21
Net Block
166.52
172.36
168.37
162.20
144.00
133.10
116.31
123.41
125.90
123.71
Gross Block
256.77
252.56
239.28
221.02
192.36
172.24
147.14
146.06
140.78
131.17
Accumulated Depreciation
90.26
80.19
70.92
58.82
48.36
39.14
30.83
22.66
14.87
7.46
Non Current Assets
292.93
284.17
273.25
249.43
213.62
185.67
164.85
157.61
157.47
159.81
Capital Work in Progress
2.47
2.51
2.60
2.60
2.56
2.47
7.54
2.45
2.47
8.95
Non Current Investment
108.84
94.77
88.89
70.00
56.31
44.96
35.47
26.64
24.38
21.83
Long Term Loans & Adv.
13.90
13.34
12.46
12.81
6.90
2.83
2.91
2.67
2.39
3.01
Other Non Current Assets
1.21
1.18
0.93
1.82
3.84
2.31
2.62
2.45
2.33
2.30
Current Assets
310.83
313.74
302.47
274.78
228.16
185.47
180.49
149.86
143.04
124.40
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
1.05
Inventories
81.09
84.31
70.57
68.95
60.81
58.49
54.61
53.63
49.58
48.44
Sundry Debtors
178.12
177.10
177.95
145.02
100.56
77.61
102.48
72.91
68.63
48.25
Cash & Bank
9.15
12.84
19.30
18.89
26.50
24.63
5.29
3.45
6.91
8.62
Other Current Assets
42.47
6.81
7.44
6.67
40.28
24.73
18.11
19.87
17.91
18.04
Short Term Loans & Adv.
36.21
32.67
27.21
35.24
34.34
18.84
12.28
14.45
12.57
12.72
Net Current Assets
138.82
147.74
140.19
125.40
104.64
57.16
25.68
3.18
18.09
0.23
Total Assets
603.76
597.91
575.72
524.21
441.78
371.14
345.34
307.47
300.51
284.21

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 26
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Cash From Operating Activity
-3.27
34.71
22.09
16.09
34.39
56.98
0.33
10.92
7.86
-1.51
PBT
1.93
39.67
53.44
72.51
95.26
41.33
26.87
-12.60
11.33
17.56
Adjustment
3.25
10.89
-1.48
0.03
-0.24
7.66
9.33
16.74
14.93
15.92
Changes in Working Capital
-2.04
-5.11
-20.92
-40.30
-42.55
7.90
-35.63
7.08
-19.05
-35.16
Cash after chg. in Working capital
3.14
45.46
31.05
32.25
52.47
56.90
0.57
11.22
7.21
-1.67
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-6.40
-10.75
-8.96
-16.15
-18.07
0.08
-0.24
-0.30
0.65
0.16
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-2.54
-12.17
-15.95
-23.96
-15.59
-15.65
-5.47
-3.72
-0.04
-4.14
Net Fixed Assets
-4.18
-13.19
-18.26
-28.70
-20.21
-20.03
-6.16
-5.34
-3.11
20.82
Net Investments
-0.01
0.06
-0.11
-0.05
-0.03
-0.02
0.06
-0.01
1.01
-1.33
Others
1.65
0.96
2.42
4.79
4.65
4.40
0.63
1.63
2.06
-23.63
Cash from Financing Activity
3.79
-25.90
-8.77
0.14
-17.55
-25.65
6.72
-9.94
-9.11
5.27
Net Cash Inflow / Outflow
-2.02
-3.36
-2.62
-7.73
1.26
15.68
1.59
-2.74
-1.29
-0.38
Opening Cash & Equivalents
6.56
9.92
12.55
20.28
19.02
3.34
1.75
4.49
5.78
6.16
Closing Cash & Equivalent
4.54
6.56
9.92
12.55
20.28
19.02
3.34
1.75
4.49
5.78

Financial Ratios

Consolidated /

Standalone
Description
Mar 26
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Book Value (Rs.)
43.28
43.74
41.03
36.88
31.22
237.41
198.67
171.54
183.39
166.38
ROA
0.19%
5.08%
7.91%
11.78%
17.93%
7.32%
4.86%
-4.29%
2.95%
5.29%
ROE
0.29%
7.65%
12.14%
18.16%
28.84%
13.09%
9.34%
-8.00%
5.42%
13.16%
ROCE
2.56%
10.37%
13.88%
20.59%
31.07%
15.21%
11.81%
-1.25%
8.52%
12.92%
Fixed Asset Turnover
1.34
1.65
1.66
1.71
2.16
1.44
1.38
1.28
1.56
1.32
Receivable days
189.42
159.79
154.39
126.49
82.40
142.49
158.78
140.57
100.75
77.33
Inventory Days
88.20
69.71
66.70
66.84
55.18
89.48
97.99
102.51
84.49
86.11
Payable days
165.63
166.51
138.08
130.58
87.30
163.89
75.58
71.78
69.42
73.88
Cash Conversion Cycle
111.99
62.99
83.02
62.75
50.27
68.08
181.20
171.29
115.83
89.56
Total Debt/Equity
0.25
0.21
0.25
0.27
0.27
0.39
0.54
0.52
0.48
0.55
Interest Cover
1.18
4.95
6.70
8.58
11.86
3.51
2.40
-0.26
1.74
2.38

Annual Reports:

FY 2026
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
FY 2019
FY 2018
FY 2017

News Update:


  • Themis Medicare - Quarterly Results
    14th Aug 2026, 00:00 AM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.